CDK2 overexpression may facilitate lymph node metastasis of early cancer, and decreased CDK2 correlates with large tumor size, venous invasion, deep infiltration, hepatic metastasis, advanced stage, and poor prognosis (Li et al., 2001). Here, CDK2 is linked to cancer.